Advances in myeloma at ASH 2012 (2/2)
Advances in myeloma at ASH 2012 (2/2)
Advances in myeloma at ASH 2012 (1/2)
Pre-Implantation genetic diagnosis
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study
Neurocognitive impact in adjuvant chemotherapy for breast cancer
Predicting late distant metastases in ER / HER2- breast cancer patients
Investigation of Ki67 biomarker
Results of a randomised phase 2 study of PD 0332991
MLN9708 in combination with lenalidomide and dexamethasone against multiple myeloma
PACE Trial: Phase II trial of ponatinib in patients with chronic myeloid leukaemia (CML)
Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer
Mammographic density and the risk and detection of breast cancer